Top Posters
Since Sunday
19
18
15
15
14
14
13
13
13
13
12
12
New Topic  
wrote...
Posts: 25
Rep: 0 0
4 months ago
A patient is undergoing a cytotoxic chemotherapy regimen for the treatment of stage III lung cancer. What effect will this regimen likely have on the patient's hemostatic function?
A)The patient's platelet count will decline.
B)The patient will be at increased risk of deep vein thrombosis.
C)The patient will require prophylactic heparin.
D)The patient will likely experience thrombocytosis.
Textbook 
Abrams' Clinical Drug Therapy: Rationales for Nursing Practice
Edition: 10th
Authors:
Read 23 times
1 Reply
Replies
Answer verified by a subject expert
wrote...
Posts: 162
4 months ago
Sign in or Sign up in seconds to unlock everything.
A
Feedback:
Thrombocytopenia is a common adverse effect of cytotoxic chemotherapy. Heparin is consequently contraindicated, and DVT is not a priority risk.

Related Topics
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers.
Learn More
Improve Grades
Help Others
Save Time
Accessible 24/7
  149 People Browsing
Related Images
 513
 343
 60